Search

everythinglearnresearchcommunity

for

Search:↓

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Hair loss is common in IBD patients, and some medications may lower the risk.

A man's gray hair got darker and thicker after using a psoriasis drug.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Garden cress extract may help treat skin inflammation and androgen-related disorders.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Tiny particles called extracellular vesicles show promise for skin improvement and anti-aging in facial care but face challenges like low production and lack of research.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Immune cells affect hair growth and could lead to new hair loss treatments.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

PRP may help with aging and osteoarthritis, improving tissue repair and reducing surgery risk.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

The document explains various skin conditions and their treatments.

Lamivudine might reverse hair graying and needs more research for potential treatments.